FDA Inspection 1108244 - Samsung Biologics Co., Ltd. - November 01, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Samsung Biologics Co., Ltd., with an inspection on November 1, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Samsung Biologics Co., Ltd.
Inspection Date: November 1, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 7097d01b-422a-4c04-aabf-43ae536c0e32

Violation Codes1

21 CFR 211.100(b)

Full citation text and observation details available on the Dashboard.